More Business News:
Millennium Reveals 7% or $6.5M Stake in Javelin - CBL
By Citybizlist Staff
CAMBRIDGE -- In a filing with the SEC, Millennium Management LLC has revealed a 7% stake in pain management company Javelin Pharmaceuticals Inc.
New York-based Millennium owns 4,460,350 shares of Javelin's common stock. Javelin (AMEX: JAV) last traded at $1.46, making Millennium's stake worth about $6.5 million. Millenium paid about $6.2 million for the shares.
Founded in 1998, Cambridge, Mass.-based Javelin Pharmaceuticals specializes in research, development, and commercialization for pain management products in Europe and the U.S.
As reported by citybizlist, Javelin plans to merge with Myriad Pharmaceuticals Inc. (Nasdaq: MYRX) late this quarter, a move that has spurred several lawsuits.
Millennium Management LLC is an international investment management firm, founded in 1989 by Israel A. Englander. Millennium purchased the Javelin shares through its subsidiaries Millenco and Integrated Core Strategies.
SEC filing: http://tinyurl.com/yfpsvpx
Bio of Principals from Millennium Management Web site
Chairman - Chief Executive Officer (founder in 1989)
The New York-headquartered firm is led by CEO and Chairman Israel Englander. Mr. Englander is the managing member of Millennium Management LLC and has more than 35 years of experience in securities and derivatives across a broad range of instruments and strategies. He worked as a floor broker and trader on the American Stock Exchange, has owned a specialist operation since 1982, is a former chairman of the Specialist Association and has served on numerous Exchange committees, including Allocations, Allocation Procedures, Emerging Company Marketplace, Options and Special Allocations. He founded the firm in 1989 with a total $35 million under management. Mr. Englander graduated from New York University with a BS in Finance and attended New York University Graduate School of Business Administration.
Co-President - Chief Operating Officer (joined in 1994)
Mr. Feeney has more than 25 years of experience in the financial services industry. Mr. Feeney previously worked as an audit partner with Ernst & Young´s New York Financial Services Office, specializing in broker-dealers and hedge funds, an experience that involved various operational, back office and regulatory projects, along with financial audits. Mr. Feeney oversees the administrative areas of the firm including finance, counterparty credit and investor relations, which collectively employ more than 200 people. Mr. Feeney graduated summa cum laude from Fordham University with a BS in Accounting.
Also at citybizlist, see:
Myriad Says Merger With Cambridge-Based Javelin on Course for Q1 Close - CBL
Javelin, Myriad Hit by Potential Class-Action Lawsuit Related to Merger Plan - CBL
8-K Alert: Javelin Pharmaceuticals Adopts Retention Plan for CFO Stephen Tulipano
